BMS-833923

Ligand id: 8202

Name: BMS-833923

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 78.94
Molecular weight 473.22
XLogP 8.04
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
BMS-833923 has reached Phase II clinical trial (in combination with dasatinib) for the treatment of leukemia. Click here to link to ClinicalTrials.gov's full listing of BMS-833923 trials.